Showing results (61-70 of 118) with videos related to
Sort By:
Pageof 12
European Journal of Heart Failure|May 3, 2022
Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortalityBenedikt Schrage, Lars H Lund, Lina Benson, et al.European Journal of Heart Failure|July 7, 2023
Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lars H Lund, Lina Benson, et al.Journal of Cardiac Failure|May 13, 2022
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure PopulationTonje Thorvaldsen, Giulia Ferrannini, Linda Mellbin, et al.European Journal of Heart Failure|June 15, 2023
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: An analysis from the Swedish Heart Failure RegistryBenedikt Schrage, Lars H Lund, Lina Benson, et al.ESC Heart Failure|November 23, 2021
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trialLars H Lund, Gianluigi Savarese, Ashwin Venkateshvaran, et al.European Journal of Heart Failure|March 12, 2022
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strataDavide Stolfo, Lars H Lund, Peter Moritz Becher, et al.European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.Human Reproduction (Oxford, England)|September 25, 2016
Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trialHelena Hognert, Helena Kopp Kallner, Sharon Cameron, et al.European Journal of Heart Failure|September 4, 2019
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure RegistryDavide Stolfo, Alicia Uijl, Lina Benson, et al.European Journal of Heart Failure|February 13, 2023
Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure RegistryChiara Cappelletto, Davide Stolfo, Nicola Orsini, et al.Pageof 12